Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Viganò

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 17, 2012
Clinical implications of HBsAg quantification in patients with chronic hepatitis BMauro Viganò, Pietro Lampertico
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Let's not forget our COVID-19-free cirrhotic patients!Mauro Viganò, Marco Carbone
Clinical Liver Disease|July 24, 2019
Mauro Viganò, Pietro Lampertico
Gastroenterology Clinics of North America|November 25, 2015
Extrahepatic Manifestations of Hepatitis C VirusMauro Viganò, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2023
Stopping nucleos(t)ide analogues treatment in non-cirrhotic HBeAg-negative patients: Yes, we can!Alessandro Loglio, Mauro Viganò
Clinical Liver Disease|April 18, 2019
Hepatitis B virus treatment: Which patients should be treated with nucleos(t)ide analogue?Mauro Viganò, Pietro Lampertico
Expert Opinion on Biological Therapy|January 6, 2011
Antiviral drugs for HBV liver diseaseMauro Viganò, Pietro Lampertico
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?Pietro Lampertico, Mauro Viganò, Massimo Colombo
Clinics in Liver Disease|August 3, 2013
Results of treatment of chronic hepatitis B with pegylated interferonMauro Viganò, Giampaolo Mangia, Pietro Lampertico
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 17, 2012
Clinical implications of HBsAg quantification in patients with chronic hepatitis BMauro Viganò, Pietro Lampertico
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2020
Let's not forget our COVID-19-free cirrhotic patients!Mauro Viganò, Marco Carbone
Clinical Liver Disease|July 24, 2019
Mauro Viganò, Pietro Lampertico
Gastroenterology Clinics of North America|November 25, 2015
Extrahepatic Manifestations of Hepatitis C VirusMauro Viganò, Massimo Colombo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 7, 2023
Stopping nucleos(t)ide analogues treatment in non-cirrhotic HBeAg-negative patients: Yes, we can!Alessandro Loglio, Mauro Viganò
Clinical Liver Disease|April 18, 2019
Hepatitis B virus treatment: Which patients should be treated with nucleos(t)ide analogue?Mauro Viganò, Pietro Lampertico
Expert Opinion on Biological Therapy|January 6, 2011
Antiviral drugs for HBV liver diseaseMauro Viganò, Pietro Lampertico
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?Pietro Lampertico, Mauro Viganò, Massimo Colombo
Clinics in Liver Disease|August 3, 2013
Results of treatment of chronic hepatitis B with pegylated interferonMauro Viganò, Giampaolo Mangia, Pietro Lampertico
Pageof 14